Evidence map›Paper›PMID 41598984›Full record

ArticleImmunoHorizons2026

Delineation of the antibody light chain biases and kinetics following primary and secondary influenza virus infections of ferrets.

Robert A Richardson, Thomas Rowe, Greg A Kirchenbaum, Xiaojian Zhang, Hua Shi, Giuseppe A Sautto, Ted M Ross

Abstract read
In one paragraph

Article in ImmunoHorizons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Robert A RichardsonCenter for Vaccines and Immunology, University of Georgia, Athens, GA, United States.ORCID 0000-0003-3702-8122
Thomas RoweCenter for Vaccines and Immunology, University of Georgia, Athens, GA, United States.
Greg A KirchenbaumImmunobiology Department, Cellular Technology Limited, Shaker Heights, Cleveland, OH, United States.
Xiaojian ZhangCenter for Vaccines and Immunology, University of Georgia, Athens, GA, United States.
Hua ShiCenter for Vaccines and Immunology, University of Georgia, Athens, GA, United States.
Giuseppe A SauttoFlorida Research and Innovation Center, Cleveland Clinic, Port Saint Lucie, FL, United States.ORCID 0000-0002-0273-2235
Ted M RossCenter for Vaccines and Immunology, University of Georgia, Athens, GA, United States.ORCID 0000-0003-1947-7469

Funding

COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,75N93019C00052 · NIAID · UNIVERSITY OF GEORGIA · PI ROSS, TED · 2019 to 2025
$74.6M
NIAID NIH HHS 75N93019C00052
6 · The paper itself

Abstract

The ferret is considered the "gold standard" animal model for influenza virus research. However, the mechanisms of the ferret humoral immune responses remain understudied. Here, the kinetic profile of the influenza A or B virus hemagglutinin (HA)-specific primary antibody response was tracked until the contraction phase. Additionally, the acute humoral response following a secondary infection with a homosubtypic H1N1 influenza A virus was evaluated. In particular, the HA-binding reactivity in serum was quantified and the number of HA-specific antibody-secreting cells was evaluated in different immune compartments, including peripheral blood mononuclear cells, spleen, and mediastinal lymph nodes at multiple time points postinfection. Differences in Igκ and Igλ light chain (IgL) usage within the elicited HA-specific antibody response was observed after primary and secondary influenza virus infection. Ferrets had de novo humoral immune responses that were detected approximately 7 to 10 days following influenza virus infection with an inherent Igλ serum antibody bias directed toward the HA head domain, with detectable hemagglutination inhibition activity. The Igλ bias was also extended to influenza B virus primary infections. Higher serum Igκ reactivity was detected following secondary influenza virus infection compared to the primary viral infection, which was directed toward the conserved H1 stem domain. Taken together, our findings confirm inherent IgL biases in the anti-HA antibody response expressed following influenza virus primary and secondary infections that result in a unique profile of antibody functional activity.

Indexed as

Antibodies, ViralImmunoglobulin Light ChainsInfluenza A Virus, H1N1 SubtypeOrthomyxoviridae InfectionsAnimalsAntibody-Producing CellsDisease Models, AnimalFemaleFerretsHemagglutinin Glycoproteins, Influenza VirusImmunity, HumoralInfluenza B virusKineticsAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusImmunoglobulin Light Chainsantibody light chainferretsinfluenza virusprimary infectionsecondary infection

Identifiers

PMID41598984
PMCPMC12836430

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.